Related Experiment Video
Updated: Oct 27, 2025

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Circulating Bile Acid Profiles: A Need for Further Examination.
Li Qi1, Yu Tian2, Yongsheng Chen2
1Department of Rheumatology and Immunology, Shengjing Hospital of China Medical University, Shenyang, 110022, Liaoning Province, China.
Altered bile acid (BA) levels are linked to metabolic disorders like obesity and type 2 diabetes. Monitoring BA profiles may help predict and manage these conditions, including metabolic associated fatty liver disease (MAFLD).
Area of Science:
- Metabolic physiology
- Chronobiology
- Biomarker discovery
Background:
- Bile acids (BAs) integrate metabolic and chronobiologic signals, influencing systemic responses to nutrient availability.
- Abnormalities in circulating BA concentration or composition are linked to metabolic disorders including obesity, type 2 diabetes mellitus (T2DM), insulin resistance (IR), and metabolic associated fatty liver disease (MAFLD).
Purpose of the Study:
- To review evidence connecting aberrant circulating BA profiles with metabolic disorders.
- To explore potential mechanisms underlying these associations.
- To evaluate the role of BA profiling as a novel biomarker for metabolic abnormalities.
Main Methods:
- Systematic literature review using PubMed.
- Keywords included "bile acids," "T2DM," "IR," and "MAFLD."
- Analysis of primary and review articles.
Main Results:
- Obese and IR individuals exhibit elevated fasting BAs but reduced postprandial increases compared to controls.
- Disrupted synchronization between feeding/fasting cycles and BA-regulated pathways may underlie these alterations.
- While BA alterations' direct link to MAFLD is unclear, elevated fasting BAs correlate with advanced fibrosis risk in MAFLD patients.
Conclusions:
- Circulating BA alterations (concentration, composition, rhythm) are associated with adverse systemic metabolic events.
- Further research into BA kinetics could aid in predicting metabolic disorders and guiding therapies.
- Dynamic monitoring of BA profiles shows promise for MAFLD patient stratification.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Bile
Bile is released when dietary fats enter...
Hepatic Drug Excretion: Influencing Factors
Serum Laboratory Studies, Stool Test, Breath Test
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Chronic Pancreatitis II: Collaborative Care
Assessment:

